965 hedge funds and large institutions have $90B invested in Biogen in 2015 Q1 according to their latest regulatory filings, with 132 funds opening new positions, 336 increasing their positions, 371 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% less repeat investments, than reductions

Existing positions increased: 336 | Existing positions reduced: 371

35% less call options, than puts

Call options by funds: $1.06B | Put options by funds: $1.64B

Holders
965
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
68
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.06B
Puts
$1.64B
Net Calls
Net Calls Change

Top Buyers

1 +$951M
2 +$438M
3 +$393M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$301M
5
IC
Institutional Capital
Illinois
+$279M

Top Sellers

1 -$585M
2 -$474M
3 -$258M
4
Goldman Sachs
Goldman Sachs
New York
-$227M
5
Jennison Associates
Jennison Associates
New York
-$221M
Name Holding Trade Value Shares
Change
Change in
Stake
776
$378K
777
$370K
778
$369K
779
$367K
780
$365K
781
$363K
782
$361K
783
$359K
784
$353K
785
$353K
786
$351K
787
$351K
788
$350K
789
$348K
790
$346K
791
$340K
792
$336K
793
$334K
794
$333K
795
$331K
796
$329K
797
$327K
798
$326K
799
$321K
800
$318K